Please login to the form below

Not currently logged in
Email:
Password:

pharma pricing

This page shows the latest pharma pricing news and features for those working in and with pharma, biotech and healthcare.

Vertex scores CF deal with Scotland, but access debate continues

Vertex scores CF deal with Scotland, but access debate continues

This is the first agreement within the UK for access to Vertex's CF medicines, and comes following a long history of pricing disagreements, most notably between the pharma company, NHS ... Vertex has faced harsh criticism from the English government,

Latest news

  • Democrats reveal pricing plan with 250-drug hit list Democrats reveal pricing plan with 250-drug hit list

    Listed drugs are costing Medicare the most each year. A leaked draft of the Democrat’s long-awaited plan on medicine pricing in the US includes a list of 250 drugs ... fulfil his promises on medicine pricing as he campaigns for re-election next year.

  • Pharma ranks bottom in Gallup poll of industry reputation Pharma ranks bottom in Gallup poll of industry reputation

    US opioid epidemic and medicine pricing to blame. People in the US are more than twice as likely to consider the pharma industry in a negative rather than a positive light, ... For pharma this year 27% positive and 58% negative ratings gave it an overall

  • Leiden reassures on key role at Vertex Leiden reassures on key role at Vertex

    Public rows between NHS England, NICE and the pharma giant over the pricing of CF drug Orkambi has cast a negative light on Leiden’s legacy. ... William Blair analysts forecast that Vertex's CF franchise will peak at sales of $10.2bn, and the company

  • White House unveils plans to reimport medicines from Canada White House unveils plans to reimport medicines from Canada

    Instead, Trump last month unveiled plans to introduce international reference pricing– another radical policy which was once unthinkable for a US administration, and also strongly opposed by pharma. ... They are all setting out their own plans for

  • Another setback on pricing as Trump drops rebate plans Another setback on pricing as Trump drops rebate plans

    Follows pharma's blocking of advertising changes. The Trump Administration has abandoned yet another pillar of its plan to reduce medicine prices in the US, this time its proposal to eliminate ... First unveiled in February, the plan was to ban rebates

More from news
Approximately 2 fully matching, plus 102 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics